Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher S Hourigan

Showing results (81-90 of 145) with videos related to

Pageof 15
Sort By:
Leukemia|December 21, 2022
Recurrent germline variant in ATM associated with familial myeloproliferative neoplasmsEvan M Braunstein, Eddie Imada, Sergiu Pasca, et al.
Transplantation and Cellular Therapy|July 5, 2023
Impact of Donor Age on Allogeneic Hematopoietic Cell Transplantation Outcomes in Older Adults with Acute Myeloid LeukemiaMuhammad Bilal Abid, Noel Estrada-Merly, Mei-Jie Zhang, et al.
Leukemia Research Reports|August 11, 2017
Successful salvage chemotherapy and allogeneic transplantation of an acute myeloid leukemia patient with disseminated <i>Fusarium solani</i> infectionSheenu Sheela, Sawa Ito, Jeffrey R Strich, et al.
Haematologica|January 28, 2017
Minimal residual disease prior to allogeneic hematopoietic cell transplantation in acute myeloid leukemia: a meta-analysisSarah A Buckley, Brent L Wood, Megan Othus, et al.
Haematologica|May 28, 2026
Real-world heterogeneity in the prognostic value of pre-transplant flow cytometry measurable residual disease in acute myeloid leukemia in first complete remission: CIBMTR analysisJesse M Tettero, Mei-Jie Zhang, Wentong Liu, et al.
Blood Neoplasia|August 14, 2025
Checkpoint immunotherapy is associated with preferential activation of tumor antigen-specific CD4<sup>+</sup> T cells in MDSElizabeth A Griffiths, Pragya Srivastava, Eduardo Cortes Gomez, et al.
Leukemia|May 23, 2024
Recommendations from the AML molecular MRD expert advisory boardStuart Scott, Alison Devonshire, Richard Dillon, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 8, 2018
Pathogenic TERT promoter variants in telomere diseasesFernanda Gutierrez-Rodrigues, Flávia S Donaires, André Pinto, et al.
Journal of Translational Medicine|July 12, 2017
Impaired B cell immunity in acute myeloid leukemia patients after chemotherapyMeghali Goswami, Gabrielle Prince, Angelique Biancotto, et al.
Biorxiv : the Preprint Server for Biology|February 20, 2025
Single Cell Spatial Transcriptomics Reveals Immunotherapy-Driven Bone Marrow Niche Remodeling in AMLGege Gui, Molly A Bingham, Julius R Herzog, et al.
Pageof 15

Showing results (81-90 of 145) with videos related to

Sort By:
Pageof 15
Leukemia|December 21, 2022
Recurrent germline variant in ATM associated with familial myeloproliferative neoplasmsEvan M Braunstein, Eddie Imada, Sergiu Pasca, et al.
Transplantation and Cellular Therapy|July 5, 2023
Impact of Donor Age on Allogeneic Hematopoietic Cell Transplantation Outcomes in Older Adults with Acute Myeloid LeukemiaMuhammad Bilal Abid, Noel Estrada-Merly, Mei-Jie Zhang, et al.
Leukemia Research Reports|August 11, 2017
Successful salvage chemotherapy and allogeneic transplantation of an acute myeloid leukemia patient with disseminated <i>Fusarium solani</i> infectionSheenu Sheela, Sawa Ito, Jeffrey R Strich, et al.
Haematologica|January 28, 2017
Minimal residual disease prior to allogeneic hematopoietic cell transplantation in acute myeloid leukemia: a meta-analysisSarah A Buckley, Brent L Wood, Megan Othus, et al.
Haematologica|May 28, 2026
Real-world heterogeneity in the prognostic value of pre-transplant flow cytometry measurable residual disease in acute myeloid leukemia in first complete remission: CIBMTR analysisJesse M Tettero, Mei-Jie Zhang, Wentong Liu, et al.
Blood Neoplasia|August 14, 2025
Checkpoint immunotherapy is associated with preferential activation of tumor antigen-specific CD4<sup>+</sup> T cells in MDSElizabeth A Griffiths, Pragya Srivastava, Eduardo Cortes Gomez, et al.
Leukemia|May 23, 2024
Recommendations from the AML molecular MRD expert advisory boardStuart Scott, Alison Devonshire, Richard Dillon, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 8, 2018
Pathogenic TERT promoter variants in telomere diseasesFernanda Gutierrez-Rodrigues, Flávia S Donaires, André Pinto, et al.
Journal of Translational Medicine|July 12, 2017
Impaired B cell immunity in acute myeloid leukemia patients after chemotherapyMeghali Goswami, Gabrielle Prince, Angelique Biancotto, et al.
Biorxiv : the Preprint Server for Biology|February 20, 2025
Single Cell Spatial Transcriptomics Reveals Immunotherapy-Driven Bone Marrow Niche Remodeling in AMLGege Gui, Molly A Bingham, Julius R Herzog, et al.
Pageof 15